These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10922432)

  • 1. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH; Hansen JF; Gibson RS; Schechtman KB; Boden WE
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment with verapamil or diltiazem in patients with acute myocardial infarction: safety and possible beneficial effects.
    Sage PR; Kiosoglous AJ; Wuttke RD; Horowitz JD
    Cardiovasc Drugs Ther; 1999 Jul; 13(4):309-13. PubMed ID: 10516866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS).
    Rengo F; Carbonin P; Pahor M; DeCaprio L; Bernabei R; Ferrara N; Carosella L; Acanfora D; Parlati S; Vitale D
    Am J Cardiol; 1996 Feb; 77(5):365-9. PubMed ID: 8602564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM
    Eur Heart J; 1993 Apr; 14(4):540-5. PubMed ID: 8472720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.
    Théroux P; Grégoire J; Chin C; Pelletier G; de Guise P; Juneau M
    J Am Coll Cardiol; 1998 Sep; 32(3):620-8. PubMed ID: 9741502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
    Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
    Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
    Boden WE
    Drugs; 1996; 52 Suppl 4():20-30. PubMed ID: 8913715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.